Cavendish plc: Showing virtue of flexible cost base
11 November 2026
Tourmaline Bio, Inc. (NASDAQ: TRML) is capturing the attention of investors with its promising position within the biotechnology sector, focusing on developing transformative medicines for immune..
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) is capturing investor attention with a compelling projection of a 196.70% potential upside. Specializing in developing therapeutics for serious retinal diseases,..
Autolus Therapeutics plc (NASDAQ: AUTL) may not yet be a household name, but this UK-based biotechnology firm is making waves with its cutting-edge approach to T..
Septerna, Inc. (NASDAQ: SEPN), a clinical-stage biotechnology company headquartered in South San Francisco, California, has captured the attention of investors with its promising pipeline of G..
Treace Medical Concepts, Inc. (NASDAQ: TMCI) is a dynamic player in the healthcare sector, specifically within the medical devices industry. Headquartered in Ponte Vedra, Florida, the..
Sage Therapeutics, Inc. (SAGE), a Cambridge, Massachusetts-based biopharmaceutical company, has recently garnered investor attention due to its impressive 265.80% revenue growth. Specializing in brain health medicines,..
Sionna Therapeutics, Inc. (NASDAQ: SION) has emerged as a compelling player in the biotechnology sector, with a significant focus on treating cystic fibrosis, a life-altering genetic..
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) is making waves in the healthcare sector, particularly within the biotechnology industry. Headquartered in Cambridge, Massachusetts, this biopharmaceutical company is at..
Tyra Biosciences, Inc. (NASDAQ: TYRA) is capturing the attention of investors as a clinical-stage biotechnology firm with a focus on precision medicines targeting fibroblast growth factor..
Altimmune, Inc. (NASDAQ: ALT) has garnered significant attention from investors, primarily due to its robust potential upside and its strategic focus on high-demand healthcare sectors. With..
Inventiva S.A. – American Depositary Shares (NASDAQ: IVA) is currently making waves in the biotechnology sector with its intriguing potential for substantial upside. Based in Daix,..
Investors are keeping a close watch on Keros Therapeutics, Inc. (NASDAQ: KROS), a clinical-stage biopharmaceutical company operating at the cutting edge of biotechnology. With a focus..
Xencor, Inc. (NASDAQ: XNCR) stands in an intriguing position within the biotechnology sector, offering compelling opportunities for investors who are eyeing the healthcare landscape. With a..
Verastem, Inc. (NASDAQ: VSTM), a development-stage biopharmaceutical company, has recently captured investor attention given its significant potential upside and unanimous buy ratings from analysts. Headquartered in..
Fortrea Holdings Inc. (FTRE), a compelling player in the Biotechnology sector, operates within the Healthcare industry and is headquartered in Durham, North Carolina. Specializing as a..
Sana Biotechnology, Inc. (SANA), a pioneering force in the biotechnology sector, has attracted significant investor interest due to its ambitious approach to utilizing engineered cells as..
Dianthus Therapeutics, Inc. (NASDAQ: DNTH), a clinical-stage biotechnology company, is making waves in the healthcare sector due to its innovative approach to treating severe autoimmune and..
GH Research PLC (NASDAQ: GHRS) is attracting considerable attention in the biotechnology sector, with a striking potential upside of 137.15% according to analysts. This Dublin-based clinical-stage..
Tectonic Therapeutic, Inc. (NASDAQ: TECX), a promising name in the biotechnology sector, is drawing significant attention from investors with a remarkable potential upside of 211.75%. Specializing..
